ALTIFLEX Trademark

Trademark Overview

On Thursday, March 31, 2022, a trademark application was filed for ALTIFLEX with the United States Patent and Trademark Office. The USPTO has given the ALTIFLEX trademark a serial number of 97340287. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, February 2, 2026. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The ALTIFLEX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Genetic engineering services, namely, the production of genetically-engineered antibodies for others
altiflex

General Information

Serial Number97340287
Word MarkALTIFLEX
Filing DateThursday, March 31, 2022
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, February 2, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements

Goods and ServicesGenetic engineering services, namely, the production of genetically-engineered antibodies for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 5, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, April 4, 2022NEW APPLICATION ENTERED
Tuesday, April 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 19, 2022ASSIGNED TO EXAMINER
Wednesday, December 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2023SOU EXTENSION 1 FILED
Wednesday, August 23, 2023SOU EXTENSION 1 GRANTED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 19, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 19, 2024SOU EXTENSION 2 FILED
Tuesday, March 19, 2024SOU EXTENSION 2 GRANTED
Wednesday, March 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 28, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 28, 2024SOU EXTENSION 3 FILED
Wednesday, August 28, 2024SOU EXTENSION 3 GRANTED
Wednesday, August 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2025SOU TEAS EXTENSION RECEIVED
Thursday, February 27, 2025SOU EXTENSION 4 FILED
Thursday, February 27, 2025SOU EXTENSION 4 GRANTED
Friday, February 28, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, September 13, 2025SOU TEAS EXTENSION RECEIVED
Friday, January 30, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, September 13, 2025SOU EXTENSION 5 FILED
Monday, February 2, 2026SOU EXTENSION 5 GRANTED
Tuesday, February 3, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

altiflex engineered antibodies others genetically production engineering services namely genetic